Skip to Main Content

Paper Details

Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators.
Pharmacoepidemiol Drug Saf
1
2018
ICD, patients, person
Author NameAffiliation
Sanket S DhruvaCenter for Outcomes Research and Evaluation
Sanket S DhruvaNational Clinician Scholars Program, Yale School of Medicine
Sanket S DhruvaVeterans Affairs Connecticut Healthcare System
Andreas CoppiCenter for Outcomes Research and Evaluation
Shu-Xia LiCenter for Outcomes Research and Evaluation
Danica Marinac-DabicCenter for Devices and Radiological Health
Frederick A MasoudiUniversity of Colorado Anschutz Medical Campus
Richard E ShawCalifornia Pacific Medical Center
Frederick WarnerCenter for Outcomes Research and Evaluation
Harlan M KrumholzCenter for Outcomes Research and Evaluation
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzYale School of Public Health
Harlan M KrumholzNational Clinician Scholars Program, Yale School of Medicine
Harlan M KrumholzCenter for Outcomes Research and Evaluation
Harlan M KrumholzNational Clinician Scholars Program, Yale School of Medicine
Harlan M KrumholzYale School of Public Health
Harlan M KrumholzYale School of Medicine
Joseph S RossCenter for Outcomes Research and Evaluation
Joseph S RossNational Clinician Scholars Program, Yale School of Medicine
Joseph S RossYale School of Public Health
Joseph S RossYale School of Medicine
  • 1 - 21

Datasets

Release 1.2